Delivery Order SPE2DB20D3103-SPE2DB23FN8C4
- Not listed
- This federal contract award, valued at $2,702.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,957,353 units of the medication Clomid 50 mg tablets, with an ultimate completion date of April 18, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $8,834.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,072,662 units of the medication Clomid 50 mg tablets, and has a completion date of April 30, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00. This IDC...
- This federal contract award, valued at $2,657.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clomid 50 mg tablets, a prescription medication, with an ultimate completion date of April 11, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,781.20 firm fixed-price delivery order is for the supply of Clomid 50 mg tablets to support federal healthcare programs. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle...
- This federal contract award, valued at $4,052.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D3011|SPE2DB25FQ0UT) for the supply of 4,568,202,240 units of the medication Clomid 50 mg tablet. The contract has a firm fixed price and an ultimate completion date of May 12, 2025. This award is not associated with a set-aside program. Amerisourcebergen...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,754.18 firm-fixed-price contract is for the delivery of 30-count bottles of the prescription drug Clomid 50 mg tablets. The contract has an ultimate completion date of December 28, 2023 and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,528.40 delivery order contract is for the provision of 4,568,175,075 units of the medication Clomid 50 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through May 8, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award, valued at $24,946.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a delivery order to supply 4,568,010,319 units of the prescription medication Clomid 50 mg tablets, with a completion date of April 24, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,043.17 firm fixed-price delivery order contract is for the supply of CLOMID 50 MG TABLET UD 30S to the DLA. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing...
- This federal contract award is for the delivery of 4,559,037,596 units of the pharmaceutical drug Clomid (clomiphene citrate 50 mg tablets) to the Defense Logistics Agency (DLA). The $5,655.74 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract has an ultimate completion date of November 9, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN8C4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,918.16 firm fixed-price delivery order covers the supply of 4,561,343,187 units of Clomid 50 mg tablets. The contract has a completion date of June 27, 2023 and was awarded on June 26, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 6/26/23 |